We first evaluated the activation status of microglial cells from human samples by qPCR and surprisingly, markers as CD11b, Iba1, TREM2 and CD33 were not significantly altered in AD patients (Fig. 1a, a3–6). This evidence concerns the gene CD33 and Alzheimer disease.